CVE-2023-7008: medium-severity vulnerability in Red Hat Cryostat 2
Systemd-resolved: unsigned name response in signed zone is not refused when dnssec=yes
Published · Updated
E-mail alert when it lands in KEV, gets a public PoC or its score goes up.
13Vexday Risk Score
No sign of exploitation. No public exploitation artifact known so far.
ssvc Trackcvss 5.9epss 0.8%
A vulnerability was found in systemd-resolved. This issue may allow systemd-resolved to accept records of DNSSEC-signed domains even when they have no signature, allowing man-in-the-middles (or the upstream DNS resolver) to manipulate records.
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:N/I:H/A:N
Affected products
Red Hat · Cryostat 2Red Hat · Red Hat Enterprise Linux 8Red Hat · Red Hat Enterprise Linux 9Related CVEs — Red Hat Cryostat 2
In the same product, most dangerous first.
CVE-2023-4911HIGHGlibc: buffer overflow in ld.so leading to privilege escalationEPSS 63.8%KEVCVE-2024-6387HIGHOpenssh: regresshion - race condition in ssh allows rce/dosEPSS 99.5%CVE-2024-3094CRITICALXz: malicious code in distributed sourceEPSS 90.9%CVE-2023-46847HIGHSquid: denial of service in http digest authenticationEPSS 78.5%CVE-2024-12084CRITICALRsync: heap buffer overflow in rsync due to improper checksum length handlingEPSS 72.5%CVE-2023-1183MEDIUMArbitrary file writeEPSS 64.9%
References
https://access.redhat.com/errata/RHSA-2024:2463https://access.redhat.com/errata/RHSA-2024:3203https://access.redhat.com/security/cve/CVE-2023-7008https://bugzilla.redhat.com/show_bug.cgi?id=2222261https://bugzilla.redhat.com/show_bug.cgi?id=2222672https://cert-portal.siemens.com/productcert/html/ssa-794697.htmlhttps://github.com/systemd/systemd/issues/25676https://lists.debian.org/debian-lts-announce/2024/09/msg00001.htmlhttps://lists.fedoraproject.org/archives/list/package-announce@lists.fedoraproject.org/message/4GMDEG5PKONWNHOEYSUDRT6JEOISRMN2/https://lists.fedoraproject.org/archives/list/package-announce@lists.fedoraproject.org/message/QHNBXGKJWISJETTTDTZKTBFIBJUOSLKL/https://security.netapp.com/advisory/ntap-20241122-0004/